MAM
DCPH

Martingale Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Martingale Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69,926
Closed -$1.1M – 867
2024
Q1 		$1.1M Sell
69,926
-600
-0.9% -$9.23K 0.02% 449
2023
Q4 		$1.14M Buy
70,526
+5
+0% +$64 0.02% 426
2023
Q3 		$897K Sell
70,521
-3,164
-4% -$43.6K 0.02% 466
2023
Q2 		$1.04M Buy
73,685
+16,639
+29% +$238K 0.02% 438
2023
Q1 		$881K Buy
57,046
+28
+0% +$468 0.02% 476
2022
Q4 		$935K Buy
57,018
+28,059
+97% +$456K 0.02% 477
2022
Q3 		$536K Sell
28,959
-10,209
-26% -$160K 0.01% 607
2022
Q2 		$516K Sell
39,168
-11,892
-23% -$131K 0.01% 637
2022
Q1 		$474K Buy
51,060
+15,404
+43% +$131K 0.01% 647
2021
Q4 		$349K Buy
35,656
+29,749
+504% +$559K ﹤0.01% 713
2021
Q3 		$201K Buy
5,907
+3
+0.1% +$96 ﹤0.01% 825
2021
Q2 		$217K Buy
+5,904
New +$229K ﹤0.01% 787

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Martingale Asset Management's DCPH Position: Q2 2024 in Review

Martingale Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 69,926 shares — an estimated $1.1M sold.

Martingale Asset Management first reported a position in DCPH in Q2 2021 and held it in 12 quarters. The position peaked at $1.14M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Martingale Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Martingale Asset Management sold 69,926 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.1M.
  • Martingale Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Martingale Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.14M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Martingale Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.